Difference between revisions of "Shi L, et al. Vitr. Cell Dev. Biol. Anim. (2015) cited as Ref 168 in DOI: 10.1038/s41392-020-0110-5 (Q9431)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 1047-1055, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): You Y, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | You Y | ||
| Property / Fourth Author string: You Y / rank | |||
| + | Normal rank | ||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Shi L, et al. Vitr. Cell Dev. Biol. Anim. (2015) cited as Ref 168 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Shi L
0 references
Fei X
0 references
Wang Z
0 references
2015
0 references
Vitr. Cell Dev. Biol. Anim.
0 references
51
0 references
PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/beta-catenin signaling pathway (English)
0 references
1047-1055
0 references
You Y
0 references
